Jo H, Radding W, Anantharamaiah G M, McDonald J M
Department of Pathology, University of Alabama, Birmingham 35294.
Biochem J. 1993 Aug 15;294 ( Pt 1)(Pt 1):19-24. doi: 10.1042/bj2940019.
Peptides representing two putative G-protein-binding motifs (GPBP1 and GPBP2) derived from insulin-receptor sequences were tested for their ability to stimulate guanosine 5'-[gamma-thio]-triphosphate (GTP[S]; 'GTP gamma S') binding to a preparation containing the 41 and 67 kDa G-proteins that are associated with the insulin receptor [Jo, Cha, Davis and McDonald (1992) Endocrinology (Baltimore) 131, 2855-2861]. GPBP2 (residues 1135-1156) specifically stimulated GTP[S] binding, whereas GPBP1 (1319-1333) did not. Substitution of Arg-1152 with Gln in GPBP2 corresponding to a mutation site in insulin-resistant patients [Cocozza, Porcellini, Riccardi, Monticelli, Condorelli, Ferrera, Pianese, Miele, Capaldo, Beguinot and Varrone (1992) Diabetes 41, 521-526] attenuated the stimulatory potency of GPBP2. Size-exclusion chromatography and studies with purified 67 kDa G-protein revealed that GPBP2 stimulated GTP[S] binding only to the 67 kDa G-protein. These studies provide evidence for a potential regulatory site for G-protein interaction with the insulin receptor in the tyrosine kinase domain.
对源自胰岛素受体序列的两个假定的G蛋白结合基序(GPBP1和GPBP2)所代表的肽段,检测了它们刺激鸟苷5'-[γ-硫代]三磷酸(GTP[S];“GTPγS”)与含有与胰岛素受体相关的41 kDa和67 kDa G蛋白的制剂结合的能力[乔、查、戴维斯和麦克唐纳(1992年)《内分泌学》(巴尔的摩)131, 2855 - 2861]。GPBP2(第1135 - 1156位氨基酸残基)特异性地刺激GTP[S]结合,而GPBP1(第1319 - 1333位氨基酸残基)则无此作用。将GPBP2中对应于胰岛素抵抗患者突变位点的第1152位精氨酸替换为谷氨酰胺[科科扎、波塞利尼、里卡尔迪、蒙蒂切利、孔多雷利、费雷拉、皮亚内塞、米耶勒、卡帕尔多、贝吉诺特和瓦罗内(1992年)《糖尿病》41, 521 - 526],减弱了GPBP2的刺激效力。尺寸排阻色谱法以及对纯化的67 kDa G蛋白的研究表明,GPBP2仅刺激GTP[S]与67 kDa G蛋白结合。这些研究为酪氨酸激酶结构域中G蛋白与胰岛素受体相互作用的潜在调节位点提供了证据。